https://scholars.lib.ntu.edu.tw/handle/123456789/632004
標題: | Challenges of mitochondrial DNA editing in mammalian cells: focus on treatment of cardiovascular disease | 作者: | Khotina, Victoria A. Ekta, Mariam Bagheri Baig, Mirza S. WEI-KAI WU Grechko, Andrey V. Sukhorukov, Vasily N. |
關鍵字: | atherosclerosis | Cardiovascular disease | ddCBE | gene editing | mito-CRISPR/Cas9 | mitochondrial DNA mutation | mitoTALEN | mtZFN | 公開日期: | 1-一月-2022 | 卷: | 6 | 來源出版物: | Vessel Plus | 摘要: | Atherosclerosis is the major cause of occurrence and development of cardiovascular disease. Mutations in mitochondrial DNA (mtDNA) can lead to the development of several pathologies. Over the last few years, there has been increasing evidence that mitochondrial dysfunction caused by mtDNA mutations is associated with atherogenesis and other diseases of the cardiovascular system. Several therapeutic approaches have been developed for the improvement of mitochondrial function, and they are mainly associated with the cellular and tissue antioxidant defense system. However, these approaches are not targeted at mtDNA mutations, which trigger the pathogenesis of disease. Gene-editing technologies could be a promising approach for the treatment of cardiovascular disease caused by mtDNA mutations. To date, such technologies have shown considerable success in mitochondrial gene editing in cell and animal models. Gene-editing technologies allow the determination of the role of mitochondrial genome mutations in the development and complication of various chronic diseases. Nevertheless, further investigation and optimization in this field is required for future human trials. This review highlights the progress and existing challenges of modern technologies and approaches to mitochondrial gene editing. |
URI: | https://vpjournal.net/article/view/5356 https://scholars.lib.ntu.edu.tw/handle/123456789/632004 |
ISSN: | 25741209 | DOI: | 10.20517/2574-1209.2022.28 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。